The lipid products of phosphoinositide 3-kinase increase cell motility through protein kinase C. 1997

M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
Department of Medicine,, Harvard Medical School, Boston, Massachusetts 02215, USA.

Phosphoinositide 3-kinase has been implicated as an activator of cell motility in a variety of recent studies, yet the role of its lipid product, phosphatidylinositol 1,4,5-trisphosphate (PtdIns-3,4,5-P3), has yet to be elucidated. In this study, three independent preparations of PtdIns-3,4,5-P3 were found to increase the motility of NIH 3T3 cells when examined utilizing a microchemotaxis chamber. Dipalmitoyl L-alpha-phosphatidyl-D-myo-inositol 3,4,5-triphosphate (Di-C16-PtdIns-3,4,5-P3) also produced actin reorganization and membrane ruffling. Cells pretreated with 12-O-tetradecanoylphorbol-13-acetate to cause down-regulation of protein kinase C (PKC) exhibited complete inhibition of cell motility induced by Di-C16-PtdIns-3,4,5-P3. These results are consistent with previous observations that PtdIns-3,4,5-P3 activates Ca2+-independent PKC isoforms in vitro and in vivo and provide the first demonstration of an in vivo role for the lipid products of the phosphoinositide 3-kinase. PtdIns-3,4,5-P3 appears to directly initiate cellular motility via activation of a PKC family member.

UI MeSH Term Description Entries
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000077191 Wortmannin An androstadiene metabolite produced by the fungi PENICILLIUM funiculosum that inhibits PHOSPHATIDYLINOSITOL-3-KINASES and alloantigen-specific activation of T-LYMPHOCYTES in human tumor cell lines. It is widely used in CELL BIOLOGY research and has broad therapeutic potential. MS 54,MS-54,MS54
D000730 Androstadienes Derivatives of the steroid androstane having two double bonds at any site in any of the rings.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
June 1997, Nature,
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
March 1999, The Journal of biological chemistry,
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
September 1998, Science (New York, N.Y.),
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
September 2003, The Journal of biological chemistry,
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
November 2007, Biochemical Society transactions,
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
September 2018, Cancer metastasis reviews,
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
November 1996, Biochemistry,
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
January 2006, European journal of pharmacology,
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
September 2013, Cellular and molecular life sciences : CMLS,
M P Derman, and A Toker, and J H Hartwig, and K Spokes, and J R Falck, and C S Chen, and L C Cantley, and L G Cantley
April 2000, The Journal of biological chemistry,
Copied contents to your clipboard!